Skip to main content

Want a detailed portfolio tracker?

Cellectis (CLLS) P/E (2015 - 2026)

Cellectis (CLLS) P/E from Mar 25, 2015 to Jul 21, 2026. The TTM Cellectis (CLLS) P/E is -4.01. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cellectis (CLLS)

YearP/EChange
2026-4.01-44.12%
2025-7.18+58.69%
2024-4.53+146.50%
2023-1.84+100.75%
2022-0.91-71.54%
2021-3.21-77.12%
2020-14.04+97.27%
2019-7.12-16.24%
2018-8.50-29.12%
2017-11.99-11.51%
2016-13.55-72.89%
2015-49.97N/A

Comparison Cellectis (CLLS) P/E with competitors

Cellectis (CLLS) P/E is -4.01.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.11%
ENLVEnlivex Ltd0.07-101.86%
FGENFibroGen Inc0.24-105.98%
CHRSCoherus Biosciences Inc0.85-121.14%
FBIOFortress Biotech Inc0.95-123.65%
ORMPOramed Pharmaceuticals Inc1.50-137.46%
AGENAgenus Inc3.01-175.00%
INVAInnoviva Inc3.15-178.60%
VXRTVaxart Inc3.55-188.46%
CRMDCorMedix Inc3.63-190.42%
CVACCureVac N.V.4.45-210.78%
GLPGGalapagos NV4.86-221.08%
SRPTSarepta Therapeutics Inc4.88-221.66%
ABEOAbeona Therapeutics Inc5.39-234.25%
ABUSArbutus Biopharma Corp5.60-239.44%
ZVRAZevra Therapeutics Inc5.89-246.71%
SPROSpero Therapeutics Inc6.23-255.21%
CGENCompugen Ltd6.31-257.34%
RIGLRigel Pharmaceuticals6.87-271.25%
SLXNSilexion Therapeutics Corp7.30-281.81%
OMEROmeros Corporation9.26-330.72%
AUPHAurinia Pharmaceuticals Inc9.58-338.85%
PLXProtalix BioTherapeutics Inc10.89-371.40%
ACADAcadia Pharmaceuticals Inc11.73-392.27%
TBPHTheravance Biopharma Inc12.26-405.56%
ADMAAdma Biologics Inc12.42-409.45%
HRMYHarmony Biosciences Holdings Inc13.82-444.39%
SABSSAB Biotherapeutics Inc14.14-452.27%
NAGENiagen Bioscience Inc14.82-469.26%
INCYIncyte Corp15.82-494.29%
REGNRegeneron Pharmaceuticals Inc15.86-495.14%
PBYIPuma Biotechnology Inc17.32-531.50%
CPRXCatalyst Pharmaceuticals Inc17.44-534.58%
EXELExelixis Inc17.54-537.04%
TGTXTG Therapeutics Inc18.97-572.62%
MDXGMimedx Group Inc20.55-612.16%
XOMAXOMA Royalty Corp22.87-670.04%
ARGXArgen X SE24.30-705.51%
CTMXCytomX Therapeutics Inc24.82-718.54%
XOMAOXOMA Royalty Corp25.34-731.59%
HALOHalozyme Therapeutics Inc25.62-738.54%
XOMAPXOMA Royalty Corp25.67-739.70%
VRTXVertex Pharmaceuticals Inc27.99-797.63%
RPRXRoyalty Pharma plc - Class A28.69-814.90%
SLNOSoleno Therapeutics Inc29.02-823.06%
ASNDAscendis Pharma A/S30.09-849.73%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1044.77%
APLSApellis Pharmaceuticals Inc39.02-1072.41%
BMRNBiomarin Pharmaceutical Inc42.21-1151.92%
KRYSKrystal Biotech Inc45.34-1229.96%
ONCBeiGene Ltd69.54-1832.95%
PHARPharming Group N.V.75.03-1969.64%
TECHBio-Techne Corp101.96-2640.81%
VCELVericel Corp109.92-2839.25%
ALNYAlnylam Pharmaceuticals Inc117.96-3039.70%
GMABGenmab140.29-3596.06%
TLXTelix Pharmaceuticals Ltd162.15-4140.86%
CORTCorcept Therapeutics Inc212.86-5404.43%